Human dopaminergic precursor (Wuhan Ruijian)
人源多巴胺能前体细胞（武汉睿健）
Report date: 2026/05/12 20:00:17
Base Information
Drug NameHuman dopaminergic precursor (Wuhan Ruijian)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesWuhan Ruijian Pharmaceutical Technology Co Ltd
China Registration ClassClass 1 therapeutic biologic in China
Develop Information
Active CompaniesWuhan Ruijian Pharmaceutical Technology Co LtdRuijian Pharmaceutical Technology (Wuhan) Co LtdiRegene Therapeutics Co Ltd +[4]
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A